☰

Julia B. Zella, Ph.D. - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
vitamins A and D
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Plum LA, Zella J, Clagett-Dame M, DeLuca HF. A New 1,25 Dihydroxy Vitamin D Analog with Strong Bone Anabolic Activity in OVX Rats with Little or No Bone Resorptive Activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 31369169 DOI: 10.1002/Jbmr.3838  0.702
2017 Pandey R, Zella JB, Zhu JG, Plum LA, Clagett-Dame M, Blaser WJ, Bedale W, DeLuca HF, Coyne DW. Pharmacokinetics of a New Oral Vitamin D Receptor Activator (2-Methylene-19-Nor-(20S)-1α,25-Dihydroxyvitamin D3) in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism on Hemodialysis. Drugs in R&D. PMID 28905271 DOI: 10.1007/S40268-017-0210-Z  0.727
2016 Thadhani R, Zella JB, Knutson DC, Blaser WJ, Plum LA, Clagett-Dame M, Buck RD, DeLuca HF. 2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial. American Journal of Nephrology. 45: 40-48. PMID 27880946 DOI: 10.1159/000452680  0.71
2016 Pandey R, Zella J, Clagett-Dame M, Plum LA, DeLuca HF, Coyne DW. Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism. American Journal of Nephrology. 43: 213-220. PMID 27096733 DOI: 10.1159/000445756  0.707
2014 Zella JB, Plum LA, Plowchalk DR, Potochoiba M, Clagett-Dame M, Deluca HF. Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women American Journal of Nephrology. 39: 476-483. PMID 24854296 DOI: 10.1159/000362846  0.718
2014 Ni Z, Qian J, Yang X, Zhang H, Hang Y, Yan H, Lin A, Huang J, Fang W, Cai J, Yu X, Zhang B, Zhang H, Fang Y, Liu S, ... ... Zella JB, et al. Contents Vol. 39, 2014 American Journal of Nephrology. 39. DOI: 10.1159/000365231  0.542
2012 Plum LA, Zella JB. Vitamin D compounds and diabetic nephropathy. Archives of Biochemistry and Biophysics. 523: 87-94. PMID 22406438 DOI: 10.1016/j.abb.2012.02.008  0.505
2009 Williams KB, Barycka K, Zella JB, DeLuca HF. Diaminobutane (DAB) dendrimers are potent binders of oral phosphate Journal of Bone and Mineral Research. 24: 97-101. PMID 18715138 DOI: 10.1359/Jbmr.080819  0.597
2006 Plum LA, Fitzpatrick LA, Ma X, Binkley NC, Zella JB, Clagett-Dame M, DeLuca HF. 2MD, a new anabolic agent for osteoporosis treatment Osteoporosis International. 17: 704-715. PMID 16491322 DOI: 10.1007/S00198-005-0036-3  0.64
2003 Zella JB, McCary LC, DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Archives of Biochemistry and Biophysics. 417: 77-80. PMID 12921782 DOI: 10.1016/S0003-9861(03)00338-2  0.61
2003 Healy KD, Zella JB, Prahl JM, DeLuca HF. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium. Proceedings of the National Academy of Sciences of the United States of America. 100: 9733-7. PMID 12900504 DOI: 10.1073/Pnas.1633774100  0.713
2003 Zella JB, DeLuca HF. Vitamin D and autoimmune diabetes. Journal of Cellular Biochemistry. 88: 216-22. PMID 12520517 DOI: 10.1002/Jcb.10347  0.621
Show low-probability matches.